HIGHLIGHTS
- who: Jennifer G. Robinson and colleagues from the Division of Cardiology, Department of Epidemiology and Internal Medicine, University of Iowa, Iowa City, IA have published the article: Clinical implications of the log linear association between LDL-C lowering and cardiovascular risk reduction: Greatest benefits when LDL-C >100 mg/dl, in the Journal: PLOS ONE of May/28,/2020
- what: The results from cardiovascular outcomes trials of statins, ezetimibe and PCSK9 mAbs support a log linear association between on-treatment LDL-C and ASCVD event rates.
- how: The findings from this analysis support . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.